CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,901 | -43.2% | 17,815 | -39.8% | 0.01% | -40.0% |
| Q4 2022 | $47,323 | -27.2% | 29,577 | -34.1% | 0.01% | -37.5% |
| Q3 2022 | $65,000 | -64.7% | 44,848 | -55.4% | 0.02% | -78.7% |
| Q2 2022 | $184,000 | -41.8% | 100,604 | -15.0% | 0.08% | -46.0% |
| Q1 2022 | $316,000 | +618.2% | 118,339 | +1064.2% | 0.14% | +456.0% |
| Q4 2021 | $44,000 | -67.6% | 10,165 | -52.5% | 0.02% | -45.7% |
| Q2 2021 | $136,000 | – | 21,422 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |